VistaGen Therapeutics Receives $1,930,281 New Funding

  • Feed Type
  • Date
    8/6/2015
  • Company Name
    VistaGen Therapeutics
  • Mailing Address
    343 Allerton Avenue South San Francisco, CA 94080 USA
  • Company Description
    VistaGen Therapeutics is a biopharmaceutical company pioneering the use of embryonic stem cells (ES cells) for drug discovery and development and predictive toxicology.
  • Website
    http://www.vistagen.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,930,281
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy